Routine screening for women at average risk is not recommended because no sufficiently accurate screening test is currently available. The pelvic examination can only occasionally detect ovarian cancer, generally when the disease is already in advanced stages.
However, the combination of a thorough pelvic exam, transvaginal ultrasound, and a blood test for the tumor marker CA125 should be offered to woman who are at high risk of ovarian cancer and to women who have symptoms. For women at average risk, transvaginal ultrasound and testing for the tumor marker CA125 may help in diagnosis but are not used for routine screening.
With Compassion, your donation is used wisely to help children around the world.
We use industry standard communication protocols to ensure your personal information is encrypted and transmitted without risk.
